The HR Business Partner serves as the primary HR lead for the Industrials segment across Europe, reporting to the Director, HR – Industrial. This role partners closely with Industrials EU leadership to drive organizational effectiveness, strengthen
At NiCE, we don’t limit our challenges. We challenge our limits. Always. We’re ambitious. We’re game changers. And we play to win. We set the highest standards and execute beyond them. And if you’re like us,
Your mission As a Working Student in Data Protection, you will support our Data Protection Officer and contribute to ensuring compliance with GDPR and other relevant data protection laws across the organisation. You will have the
Company Description Imagine a world where life-saving medicines and vaccines reach those who need them most, faster and more safely. At EXTEDO, this is not just a vision - it’s our daily mission. We are driven
The Channel Company is the global leader in data-driven growth acceleration solutions and services for the IT channel. With 40+ years of channel expertise and a premier portfolio of editorial brands, marketing and event services, and
District Channel Development Manager – Region West Germany Location: home office in the region OR Fortinet Frankfurt office Our market position and solution effectiveness have been widely validated by industry analysts, independent testing labs, business organizations,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
Company Description Zayo Europe’s journey has been guided by an aspirational vision for connectivity. Our founders were veterans of the companies that constructed the earliest backbone of the Internet. They understood that truly putting “the world”